New point of attack against stomach bacterium Helicobacter pylori

December 20, 2016

There is a strong suspicion that Helicobacter pylori is linked to the development of stomach cancer. Now an international team of researchers led by Prof. Donald R. Ronning (University of Toledo, USA) has used neutrons to unlock the secret to the functionality of an important enzyme in the bacterium's metabolism. This could be used as a point of attack for new medications. The team made the corresponding measurements at the neutron sources in Oak Ridge (USA) and at the research neutron source FRM II of the Technical University of Munich (TUM).

One in every two people everywhere in the world has it in his or her stomach: Helicobacter pylori. Ulcers and chronic gastritis are the most common illnesses associated with this bacterium. Up to now the standard therapy used to combat this stomach germ has been a combination of two antibiotics and a proton pump inhibitor. But this treatment is only successful in 70 percent of cases, and an increasing level of resistance is developing. For quite some time now scientists have therefore been searching for alternative medications to fight this dangerous bacterium.

In contrast to humans and to many helpful bacteria, H. pylori uses a special enzyme to synthesize vitamin K2. As a result, this enzyme, 5'-methylthioadenosine nucleosidase (MTAN), offers very promising prospects for the development of a medication that acts specifically against H. pylori without harming useful bacteria or even human cells.

Structural determination with neutrons

The enzyme MTAN is part of an important step in the synthesis of vitamin K2. Hydrogen bonds bind a precursor of the vitamin in order to cut off a side chain. But the positions and position changes of the hydrogen atoms essential to this process were not previously known with certainty.

The usual method of structural determination for enzymes, crystal structure analysis using x-ray radiation, is of little help here, since the x-ray radiation is almost blind to hydrogen atoms. Therefore, the researchers based their structural determination on neutrons, which are particularly sensitive to hydrogen atoms.

The scientists investigated different variations of the enzyme at the BIODIFF diffractometer, operated jointly by the TUM and the Jülich Centre for Neutron Science (JCNS) in the Heinz Maier-Leibnitz Zentrum in Garching north of Munich, and at the Oak Ridge National Laboratory (USA) neutron source. The joint measurements allowed them draw a detailed picture of the enzyme's mode of action.

"Now that we know the exact process of the reaction and the binding sites of the enzyme involved, it's possible to develop molecules that block exactly this process," says TUM biologist Andreas Ostermann, who supervises the instrument at the FRM II together with Dr. Tobias Schrader (JCNS).
The publication included researchers from the University of Toledo (Toledo, USA), Victoria University of Wellington (New Zealand), the Heinz Maier-Leibnitz research neutron source at the Technical University of Munich (TUM), the Jülich Centre for Neutron Science and the Oak Ridge National Laboratory (USA). The research was supported by funds from the Center for the Advancement of Science in Space (USA) and the National Institute of Allergy and Infectious Disease (USA). X-ray structure data were measured at the Advanced Photon Source of the Argonne National Laboratory (USA) with the support of the Michigan Economic Development Corporation.


Neutron structures of the Helicobacter pylori 5?-methylthioadenosine nucleosidase highlight proton sharing and protonation states
Michael T. Banco, Vidhi Mishra, Andreas Ostermann, Tobias E. Schrader, Gary B. Evans, Andrey Kovalevsky, and Donald R. Ronning
PNAS, November 16, 2016, doi:10.1073/pnas.1609718113

Technical University of Munich (TUM)

Related Enzyme Articles from Brightsurf:

Repairing the photosynthetic enzyme Rubisco
Researchers at the Max Planck Institute of Biochemistry decipher the molecular mechanism of Rubisco Activase

Oldest enzyme in cellular respiration isolated
Researchers from Goethe University have found what is perhaps the oldest enzyme in cellular respiration.

UQ researchers solve a 50-year-old enzyme mystery
Advanced herbicides and treatments for infection may result from the unravelling of a 50-year-old mystery by University of Queensland researchers.

Overactive enzyme causes hereditary hypertension
After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure.

Triggered by light, a novel way to switch on an enzyme
In living cells, enzymes drive biochemical metabolic processes. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics.

A 'corset' for the enzyme structure
The structure of enzymes determines how they control vital processes such as digestion or immune response.

Could inhibiting the DPP4 enzyme help treat coronavirus?
Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

Bacterial enzyme could become a new target for antibiotics
Scientists discover the structure of an enzyme, found in the human gut, that breaks down a component of collagen.

Chemists create new artificial enzyme
Rajeev Prabhakar, a computational chemist at the University of Miami, and his collaborators at the University of Michigan have created a novel, synthetic, three-stranded molecule that functions just like a natural metalloenzyme, or an enzyme that contains metal ions.

First artificial enzyme created with two non-biological groups
Scientists at the University of Groningen turned a non-enzymatic protein into a new, artificial enzyme by adding two abiological catalytic components: an unnatural amino acid and a catalytic copper complex.

Read More: Enzyme News and Enzyme Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to